Statement
5 Apr 2024
Enhanced collaboration between anti-doping agency and big pharma bolsters support for clean sport among athletes
On 3 April 2024 in Athens, the International Federationof Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a joint letter of intent.
Read more
Statement
1 Feb 2023
Substandard and falsified medical products (EB152)
On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.
Read more
Statement
10 Jun 2021
IFPMA and local pharmaceutical industry associations call on the African and global health communities to raise awareness about the dangers of substandard and falsified medical products
On World Anti-counterfeit day, 10 June 2021, the IFPMA hosted a joint event with local Pharmaceutical Industry Associations from across the African continent to tackle the topic of falsified medicines and chart a robust response to eliminate falsified medicines in the region.
Read more